COMMUNIQUÉS West-GlobeNewswire

Lexaria Bioscience Corp. Discusses The Importance of New Subsidiaries and Intellectual Property with Uptick Newswire’s Stock Day Podcast

23/10/2018 - 15:00

PHOENIX, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQX: LXRP ) (CSE: LXX) (the “Company” or “Lexaria”) is a drug delivery platform innovator that has developed and out-licenses its disruptive [...]

Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2018

23/10/2018 - 15:00

SALT LAKE CITY, Oct. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- In the third calendar quarter (3Q) and first nine months (9M) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved results which conform with [...]

Village Farms Exclusive Onsite Video and Interview -- CFN Media

23/10/2018 - 15:00

SEATTLE, Oct. 23, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018

23/10/2018 - 14:30

BRIDGEWATER, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will release [...]

Vericel to Report Third-Quarter 2018 Financial Results on November 6, 2018

23/10/2018 - 14:30

CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]

PSIQ Files Form S-1 as First Step to Becoming an SEC Reporting Company and Uplisting to OTCQB

23/10/2018 - 14:30

SUNRISE, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) [...]

Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018

23/10/2018 - 14:30

ROCHESTER, N.Y., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]

Terra Tech Corp. Completes Sale of Western Avenue, Nevada Retail Dispensary for $6.25 million

23/10/2018 - 14:30

IRVINE, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, has completed its previously announced [...]

Zosano Treats over 4,000 Migraines and Reaches an Important Goal in M207-ADAM Long-term Safety Study

23/10/2018 - 14:30

FREMONT, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that more than 150 evaluable subjects [...]

Portola Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018

23/10/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results for [...]

Bespoke Extracts Applauds 16-Yr Old Racing Rookie Sean Kelly for Big First Place Finish at Daytona Race of Champions

23/10/2018 - 14:30

SUNNY ISLES, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD products, is pleased to congratulate Hairy Kiwi/Bespoke CBD-sponsored [...]

Veritas Announces Investment Into Cannabis Growing Facility Under Health Canada License

23/10/2018 - 14:15

VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce a $1.25 million investment to acquire [...]

Trinity Biotech Announces Results for Q3, 2018

23/10/2018 - 14:05

DUBLIN, Ireland, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]

Ceapro Inc. Receives the 2018 Award for Most Innovative Raw Material at Cosmetics 360 Salon in Paris

23/10/2018 - 14:05

New chemical complex, beta glucan-Co enzyme Q10, attracts special attention as a potentially strong antioxidant to be incorporated in a new formulation from Company’s proprietary cosmeceutical products, Juvente DC [...]

SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for Treatment of Rheumatoid Arthritis (RA)

23/10/2018 - 14:01

Successful proof-of-concept study demonstrates positive long-term 24-month safety and efficacy data Results to be Presented in Two Poster Presentations Today during the American College of Rheumatology (ACR) / [...]

Neuronetics to Report Third Quarter 2018 Financial Results and Host Conference Call

23/10/2018 - 14:00

MALVERN, Pa., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]

Daré Bioscience, Inc. to Present at the Dawson James Small Cap Growth Conference

23/10/2018 - 14:00

SAN DIEGO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced that John Fair, Chief Business Officer, will present at the Dawson [...]

Fulgent Genetics to Announce Third Quarter 2018 Financial Results on Tuesday November 6, 2018

23/10/2018 - 14:00

TEMPLE CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2018 financial results after the [...]

Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics' Lead Drug Candidate VB-111 until October 2033

23/10/2018 - 14:00

TEL AVIV, Israel, Oct. 23, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced the issuance by the European Patent Office (EPO) of Patent No. 2908865, a composition of matter patent which covers VB- [...]